Literature DB >> 20720496

Less is not always more: sugammadex and the risk of under-dosing.

Thomas Fuchs-Buder.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20720496     DOI: 10.1097/EJA.0b013e32833dce3a

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


× No keyword cloud information.
  7 in total

1.  Efficacy of different doses of sugammadex after continuous infusion of rocuronium.

Authors:  Diego Soto Mesa; Mounir Fayad Fayad; Laura Pérez Arviza; Verónica Del Valle Ruiz; Fernando Cosío Carreño; Luis Arguelles Tamargo; Manuel Amorín Díaz; Sergio Fernández-Pello Montes
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

2.  [Neuromuscular residual block : Unavoidable risk or reliably treatable?]

Authors:  T Fuchs-Buder
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

3.  Sugammadex rescue following prolonged rocuronium neuromuscular blockade with 'recurarisation' in a patient with severe renal failure.

Authors:  Steven Lobaz; Mario Sammut; Anand Damodaran
Journal:  BMJ Case Rep       Date:  2013-02-07

4.  Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice.

Authors:  Thomas Ledowski; Jing Shen Ong; Tom Flett
Journal:  Anesthesiol Res Pract       Date:  2015-01-22

5.  Monitoring of Sugammadex Dosing at a Large Tertiary Care Pediatric Hospital.

Authors:  Faizaan Syed; Mehdi Trifa; Joshua C Uffman; Dmitry Tumin; Joseph D Tobias
Journal:  Pediatr Qual Saf       Date:  2018-10-09

Review 6.  Sugammadex: Appropriate Use in the Context of Budgetary Constraints.

Authors:  Guy Cammu
Journal:  Curr Anesthesiol Rep       Date:  2018-03-20

Review 7.  Advantages and pitfalls of clinical application of sugammadex.

Authors:  Hyung Young Lee; Ki Tae Jung
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.